Dedicated solution for the preclinical evaluation of inhaled products and aerosol therapies

12 October 2021

You are developing a drug candidate and want to explore a new delivery route to target your objective in clinics?

You need to assess the pharmacological and safety profile as well as the efficacy of your lead candidate delivered by inhalation or nebulization?

Cynbiose offers a range of preclinical services, dedicated to these specific routes of administrations, both in vitro and in a gold standard model in vivo model.


More information on our dedicated offer is available on our web site , please contact us to discuss your projects and needs.

Share this!